B'spoke Therapeutics unveils AI-driven drug discovery to combat metabolic diseases
Translate
B’spoke Therapeutics has launched an AI-driven drug discovery platform that uses advanced genetic and metabolic analysis to engineer precision formulations aimed at preventing metabolic diseases before symptoms begin, marking a shift from traditional supplements to science-based preventive healthcare
B’spoke Therapeutics has launched an AI-driven drug discovery platform that uses advanced genetic and metabolic analysis to engineer precision formulations aimed at preventing metabolic diseases before symptoms begin, marking a shift from traditional supplements to science-based preventive healthcare.
Comments
Leave a comment